These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Clozapine in China. Tang YL; Mao PX; Jiang F; Chen Q; Wang CY; Cai ZJ; Mitchell PB Pharmacopsychiatry; 2008 Jan; 41(1):1-9. PubMed ID: 18203045 [TBL] [Abstract][Full Text] [Related]
28. Long-term efficacy and tolerability of clozapine combined with ziprasidone or risperidone. Kuwilsky A; Krumm B; Englisch S; Dressing H; Zink M Pharmacopsychiatry; 2010 Aug; 43(6):216-20. PubMed ID: 20589598 [TBL] [Abstract][Full Text] [Related]
29. Frequencies of four genetic polymorphisms in the CYP1A2 gene in Turkish population. Bilgen T; Tosun O; Luleci G; Keser I Genetika; 2008 Aug; 44(8):1133-6. PubMed ID: 18825963 [TBL] [Abstract][Full Text] [Related]
30. Clozapine use in Australia. Malalagama G; Bastiampillai T; Dhillon R Australas Psychiatry; 2011 Apr; 19(2):175. PubMed ID: 21443399 [No Abstract] [Full Text] [Related]
31. Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: V. Association of CYP1A2 1545 C>T polymorphism. Tiwari AK; Deshpande SN; Lerer B; Nimgaonkar VL; Thelma BK Pharmacogenomics J; 2007 Oct; 7(5):305-11. PubMed ID: 16969362 [TBL] [Abstract][Full Text] [Related]
32. Possible levomepromazine-clozapine interaction: two case reports. Bugamelli F; Mandrioli R; Kenndler E; Bartoletti C; Boncompagni G; Raggi MA Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):567-70. PubMed ID: 17174461 [TBL] [Abstract][Full Text] [Related]
33. Salivary flow rate in patients with schizophrenia on clozapine. Praharaj SK; Jana AK; Goswami K; Das PR; Goyal N; Sinha VK Clin Neuropharmacol; 2010 Jul; 33(4):176-8. PubMed ID: 20661023 [TBL] [Abstract][Full Text] [Related]
34. [Obsessive-compulsive symptoms in schizophrenia during treatment with clozapine and conventional antipsychotic drugs]. Galvez-Buccollini JA; Fiestas F; Herrera P; Vega-Dienstmaier JM; Guimas B; Mazzotti G Actas Esp Psiquiatr; 2004; 32(4):211-5. PubMed ID: 15232749 [TBL] [Abstract][Full Text] [Related]
35. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003. Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060 [TBL] [Abstract][Full Text] [Related]
36. Flexibilization in controlling the use of clozapine: A great opportunity. Álvarez de Morales Gómez-Moreno E; Muquebil Ali Al Shaban Rodríguez OW; Fernández Fernández J; Fresno García C Rev Psiquiatr Salud Ment (Engl Ed); 2018; 11(4):255-256. PubMed ID: 29486914 [No Abstract] [Full Text] [Related]
38. Clozapine Metabolism in East Asians and Caucasians: A Pilot Exploration of the Prevalence of Poor Metabolizers and a Systematic Review. Ruan CJ; Zang YN; Wang CY; Cheng YH; Sun C; Spina E; de Leon J J Clin Psychopharmacol; 2019; 39(2):135-144. PubMed ID: 30811372 [TBL] [Abstract][Full Text] [Related]
40. Is there a future for Ruan CJ; de Leon J Pharmacogenomics; 2020 Apr; 21(6):369-373. PubMed ID: 32308139 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]